kailera – Lab DB

Pharmaceutical R&D

Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development

Teuku Ryan Apr 17, 2026 0

Obesity-focused biotechnology firm Kailera Therapeutics has successfully launched its Initial Public Offering (IPO), raising an impressive $625 million. This significant…

Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development

YOU MAY HAVE MISSED

Stanford Medicine Researchers Discover Glucose Functions as a Master Regulator of Stem Cell Differentiation Beyond Energy Production

Pioneering New Tool Maps Brain’s Waste Disposal Routes, Revealing Crucial Insights into Neurological Health and Disease

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus